Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2005 by Hillel Yaffe Medical Center.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT00271128
First received: December 29, 2005
Last updated: March 19, 2008
Last verified: December 2005
  Purpose

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.


Condition
Shortness of Breath
Acute Exacerbation

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward (BNP4EVER)

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Estimated Enrollment: 500
Study Start Date: October 2005
Estimated Study Completion Date: September 2007
Detailed Description:

The proposed study intends to evaluate the impact of the NT-proBNP assay on the diagnosis of heart failure in patients with dyspnea of unknown etiology presenting to the emergency room and admitted to the medical wards.

Patients will be consented and randomized to open or blinded NT-proBNP test performed within 90 minutes in a venous blood sample.

Evaluation of the ER diagnosis and final discharge diagnosis in admitted patients will be carried out in light of the NT-proBNP results.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Acute shortness of breath of unknown etiology as presentation to the emergency room
  2. Possible acute exacerbation of known heart failure

Exclusion Criteria:

None -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00271128

Locations
Israel
Hillel Yaffe Medical Center
Hadera, Israel
Sponsors and Collaborators
Hillel Yaffe Medical Center
Investigators
Principal Investigator: Simcha R Meisel, MD MSc Hillel Yaffe Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00271128     History of Changes
Other Study ID Numbers: hymc34/2005
Study First Received: December 29, 2005
Last Updated: March 19, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hillel Yaffe Medical Center:
NT-proBNP
Heart failure
Dyspnea

Additional relevant MeSH terms:
Dyspnea
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms
Signs and Symptoms, Respiratory

ClinicalTrials.gov processed this record on November 20, 2014